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Jumonji histone demethylases catalyze removal of
methyl marks from lysine residues in histone proteins
within nucleosomes. Here, we show that the catalytic
domain of demethylase JMJD2A (cJMJD2A) utilizes
a distributive mechanism to remove the histone H3
lysine 9 trimethyl mark. By developing a method to
assess demethylation of homogeneous, site-specif-
ically methylated nucleosomes, we determined that
the kinetic parameters for demethylation of nucleo-
somes by cJMJD2A are comparable to those of
peptide substrates. These findings imply that other
domains of the demethylase or its protein partners
may contribute to nucleosome recognition in vivo
and, in this way, may further regulate demethylation
activity and processivity. The quantitative assays
of nucleosome demethylation developed in our
work provide a platform for future work with complex
chromatin substrates and full-length demethylases.
INTRODUCTION
Histones, protein components of nucleosomes, are subject to
diverse posttranslational modifications. These modifications
are predominantly found in the N-terminal tails of histones and
have a profound impact on the regulation of transcription.
Methylation of lysine 9 in histone H3 (H3 K9) is a conserved eu-
karyotic modification that demarcates heterochromatin, a tran-
scriptionally silent chromatin state. Trimethylated H3 K9 (H3
K9me3) is required for heritable gene silencing, formation of cen-
tromeres, andmaintenance of telomere stability (Grewal and Jia,
2007). H3 K9 methylation has also been observed at genes that
are transcriptionally silenced in cancer (Kondo et al., 2004). The
extent (mono-, di-, or tri-) and the half-life of methylation are
controlled by opposing actions of histone methyltransferases
and demethylases, as well as histone turnover.
Removal of methyl groups from lysine residues in histones is
carried out by two classes of demethylases: the flavin-depen-494 Chemistry & Biology 20, 494–499, April 18, 2013 ª2013 Elsevierdent lysine-specific demethylase family consisting of LSD1 and
LSD2 (Karytinos et al., 2009; Shi et al., 2004), as well as the
iron- and a-ketoglutarate-dependent Jumonji C domain-con-
taining demethylases (Klose et al., 2006a; Kooistra and Helin,
2012). The Jumonji family proteins catalyze a wide set of deme-
thylation reactions on histone substrates, including removal of
methyl marks from H3 K4, H3 K9, H3 K27, H3 K36, and H4
K20 (Kooistra and Helin, 2012). Common to these proteins is
their ability to oxidize methyl groups of methylated lysine sub-
strates to form hemiaminal intermediates. Subsequent release
of formaldehyde yields demethylated product (Figure 1A) (Cloos
et al., 2006; Ng et al., 2007; Tsukada et al., 2006).
The removal of transcriptionally repressive H3 K9me3 marks
is carried out by the JMJD2 (also known as the KDM4) family
of demethylases (Cloos et al., 2006; Fodor et al., 2006; Klose
et al., 2006b; Whetstine et al., 2006). Overexpression of several
members of the JMJD2 family have been implicated in various
diseases (Berry et al., 2012; Cloos et al., 2006; Kawazu et al.,
2011; Rui et al., 2010), underscoring the importance of precise
regulation of demethylation. Members of the JMJD2 family
contain JmjN, JmjC, two plant homeodomains (PHD domains),
and a tandem Tudor domain (Figure 1B). While JmjN and
JmjC domains form a composite active site (Couture et al.,
2007; Ng et al., 2007), the double Tudor domain is thought
to allow recruitment of demethylases to their target sites by
binding H3 K4me3 and H4 K20me3 marks (Lee et al., 2008).
The function of PHD domains in JMJD2 family is yet to be
determined.
The biological significance of this demethylase family has
prompted an investigation into its kinetic and structural features
(Couture et al., 2007; Hillringhaus et al., 2011; Hopkinson et al.,
2010; Krishnan et al., 2012; Ng et al., 2007). In all of these
studies, a catalytic construct consisting of JmjN and JmjC
domain was used (cJMJD2A). To date, there is no published ki-
netic data on the full-length enzyme. Additionally, no kinetic
studies have evaluated the ability of any demethylase to remove
methyl marks from intact and homogenously modified nucleo-
somes, a necessary first step in the analysis of the demethylation
of chromatin substrates.
Herein, we analyzed the intrinsic processivity and nucleosome
demethylation ability of cJMJD2A. Our study reveals that the
cJMJD2A uses a distributive mechanism to affect multipleLtd All rights reserved
Figure 1. Catalysis and Domain Architecture of JMJD2A
(A) The abbreviated catalytic mechanism of Jumonji histone demethylases
showing the hemiaminal intermediate.
(B) Domain organization in JMJD2A.
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of homogeneous site-specifically methylated nucleosomes has
allowed us to compare the kinetic parameters for demethylation
of nucleosomes and histone tail peptides. Our findings suggest
that nucleosome recognition is not intrinsic to cJMJD2A and
may be mediated by other domains in JMJD2A or its interacting
partners. These domains and protein partners could provide a
regulatory mechanism for demethylase activity and processivity
in vivo. The ability to measure rates of demethylation of homog-
enous, site-specifically modified nucleosomes sets the stage for
analysis of the demethylation of more complex chromatin sub-
strates by JMJD2A and other demethylases.
RESULTS
Kinetic Analysis of Peptide Demethylation by cJMJD2A
To eliminate possible artifacts due to the presence of an affinity
tag, we used a tagless catalytic domain construct where the hex-
ahistidine tag had been removed from cJMJD2A (amino acids 1–
350 of JMJD2A) after purification (see Supplemental Experi-
mental Procedures available online). Using a fluorescent assay
that follows the formation of the demethylation byproduct form-
aldehyde (Couture et al., 2007), demethylation of tri- and dime-
thylated H3 K9 peptides corresponding to amino acids 7–14 of
the histone H3 tail (ARKme3STGGK and ARKme2STGGK) by
cJMJD2A was analyzed (Figures 2A and 2B). In these assays,
ARKme3STGGK is demethylated more efficiently than
ARKme2STGGK. The dimethylated peptide exhibited a 6-fold
increase in KM and a 2-fold decrease in turnover number
compared to the trimethylated peptide (KM = 410 mM, kcat =
1.0 min1 for ARKme2STGGK and KM = 67 mM, kcat =
1.8 min1 for ARKme3STGGK).
We usedmass spectrometry (MS) tomeasure the extent of de-
methylation of the trimethylated substrate as a function of time
(Figure 2C). The rapid disappearance of trimethylated species
and accumulation of dimethylated intermediates further support
the observation that cJMJD2A demethylates ARKme3STGGKChemistry & Biology 20,more efficiently than ARKme2STGGK. A slow decay of the
dimethyl species and concomitant increase in monomethyl spe-
cies past the initial 4 hr of incubation suggest that the enzyme is
mostly inactive by this time.
Two consecutive demethylations are required for the forma-
tion of monomethylated product from the starting trimethylated
peptide. The serial demethylation events can proceed by a proc-
essive or distributive mechanism. In a processive demethylation
mechanism, the release of the intermediate dimethylated prod-
uct from the enzyme is substantially slower than its conversion
to monomethylated product. In such a scenario, essentially all
the dimethylated species exists as bound to the enzyme, and
thus this intermediate cannot accumulate to amounts exceeding
the concentration of the enzyme. In contrast, in a distributive
mechanism, release of dimethylated intermediate is substantially
faster than its conversion to monomethylated product. In such a
scenario, the dimethylated intermediate can accumulate in solu-
tion to levels that are greater than the concentration of the
enzyme. The time course of demethylation by MS strongly sug-
gests that the dimethylated species accumulates to amounts
greater than that of the enzyme (Figure 2C), implying that deme-
thylation by cJMJD2A proceeds via a distributive mechanism.
We sought to confirm this observation further in an inde-
pendent experiment performed with trimethylated peptide
ARKme3STGGK with the biotin tag attached to the ε-amino
group of the C-terminal lysine (Figure 3). The kinetic parameters
for demethylation of this peptide (Figure S1) are similar to that of
nonbiotinylated peptide (Figure 2). Biotinylated ARKme3STGGK
(150 mM) was incubated with the demethylase (5 mM), and the
extent of demethylation was monitored over time by MALDI-
TOF MS. In an analogy to experiments performed with untagged
peptide (Figure 2C), accumulation of dimethylated species in
excess of enzyme concentration was observed in all time points.
This is consistent with the distributive demethylation, where the
formation of monomethylated product observed in later time
points requires rebinding of dimethylated species. The obser-
vation that demethylation of both biotinylated and unlabeled
trimethylated peptides results in accumulation of dimethylated
intermediate in amounts exceeding the concentration of the
enzyme strongly supports the distributive nature of cJMJD2A.
Demethylation of Nucleosomes
To assess the ability of cJMJD2A to demethylate nucleosomes,
we prepared homogeneous, site-specifically modified nucleo-
somes using methyllysine analogs (MLAs) (Simon et al., 2007).
In this method, a methyl lysine mimic is incorporated into histone
H3 via alkylation of a mutant cysteine residue substituting lysine
9 in histone H3, and the modified histone is subsequently incor-
porated into recombinant nucleosomes (Figure 4A). To compare
demethylation kinetics quantitatively between analog-modified
and native substrates, we first determined cJMJD2A activity
on a trimethyllysine analog peptide ARKCme3STGGK (Fig-
ure 4B). We observed an 4-fold decrease in kcat (0.48 min1)
and a 5-fold increase in KM (330 mM) as compared to endoge-
nous trimethylated peptide (Figure 2A), consistent with the find-
ings of others (Krishnan et al., 2012).
Demethylation of nucleosomes by cJMJD2A was carried out
under single-turnover conditions with excess enzyme, a method
that better enables the measurement of rates of the catalytic494–499, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 495
Figure 2. Kinetic Analysis of cJMJD2A-
Mediated Demethylation of Peptides
(A and B) Michaelis-Menten plots of initial
velocity as a function of the concentration of
ARKme3STGGK (A) and ARKme2STGGK (B). Ex-
periments were done in triplicate and are repre-
sented as mean ± SEM.
(C) Demethylation of ARKme3STGGK (200 mM) by
cJMJD2A (1 mM) monitored over time using liquid
chromatography-tandem MS. Formation of dime-
thylated species ([ARKme2STGGK]  150 mM at
15 min) in amounts that largely exceed enzyme
concentration supports distributive demethylation.
Lines connecting data points are introduced to
facilitate visualization and do not represent kinetic
fits. For experimental conditions and procedures,
see Supplemental Experimental Procedures.
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methylation was monitored by quantitative western blotting us-
ing antibodies specific for H3 K9me3 and H4. To ensure protein
quantification accuracy, the amounts of nucleosomes used
in these experiments were within the linear detection range
of these antibodies (Figure S2A). It is important to note that,
under these conditions, no cross-reactivity was observed
between H3 K9me3-specific antibody and mono- and dimethyl
recombinant MLA nucleosomes (Figure S2B). By using H3
K9me3-specific antibody to monitor disappearance of starting
material and an antibody against H4 as a loading control, we
were able to monitor the loss of the trimethylated nucleosome
substrate as a function of enzyme concentration. In these
experiments, nucleosome concentration was kept constant at
300 nM, while the concentration of cJMJD2A was varied be-
tween 50 and 400 mM. For each enzyme concentration, the ratio
of H3 KC9me3 to H4 signal was monitored as a function of time,
which is used to determine the first-order rate constant for start-
ing material consumption (kobs) (Figure 4C). A catalytic step rate
(kmax) of 0.16 min
1 and an apparent KM (K0M) of 240 mM were
determined by nonlinear regression analysis of observed first-
order rate constants as a function of enzyme concentration (Fig-
ure 4D). Due to the presence of thioether moiety, it is possible
that the thioether backbone of an MLA can undergo oxidation496 Chemistry & Biology 20, 494–499, April 18, 2013 ª2013 Elsevier Ltd All rights reservedunder demethylation conditions, possibly
precluding the trimethyl epitope recogni-
tion. However, MS analysis of MLA pep-
tide indicates negligible oxidation during
the reaction (Figure S3).
DISCUSSION
Histone methylation, a posttranslational
modification critical to the regulation
of transcription, is controlled by the
opposing actions of histone methyltrans-
ferases and demethylases. Tight control
of the site and extent of methylation
(mono-, di-, or trimethylation) is crucial
for proper cellular function. Jumonji his-
tone demethylases are critical regulatorsof nucleosomal methylation, and their misregulation is associ-
ated with cancer and neurological disorders (Kooistra and Helin,
2012). By antagonizing repressive H3 K9 di- and trimethylation,
enzymes belonging to JMJD2 family of demethylases have a
crucial impact on transcription, an effect well studied in the
context of nuclear hormone-receptor-mediated transcription
(Wissmann et al., 2007). Herein, we report our findings on the
processivity and kinetic analysis of nucleosome demethylation
by cJMJD2A. Determining the intrinsic behavior of the catalytic
domain of JMJD2A provides a better understanding of how
this demethylase may be regulated.
The ability of cJMJD2A to catalyze demethylation was first
analyzed onmethylated histone tail peptides. The kinetic param-
eters obtained show high turnover for this family of enzymes—
kcat(ARKme3STGGK) = 1.8 min
1; kcat(ARKme2STGGK) =
1.0 min1 (Figure 2)—indicating that enzyme obtained in this
manner is well behaved and comparable to themost active prep-
arations published (Krishnan et al., 2012). Our findings also
indicate that the trimethylated peptide is a better substrate
than the dimethylated variant for cJMJD2A, predominantly
due to differences in KM: KM(ARKme3STGGK) = 67 mM;
KM(ARKme2STGGK) = 410 mM. The preference for trimethylated
substrate is consistent with previous reports using His-tagged
catalytic constructs of JMJD2A (Couture et al., 2007;
Figure 3. Demethylation of Biotinylated
ARKme3STGGK by cJMJD2A
Peptide (150 mM) was incubated with the deme-
thylase (5 mM), and the extent of demethylation
over time analyzed by MALDI-TOF MS.
See also Figure S1.
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thylation of the trimethylated peptide over time showed the rapid
disappearance of trimethylated species and the accumulation of
the intermediate dimethylated peptide, which slowly decays to a
monomethyl product (Figure 2C). These findings are consistent
with our kinetic measurements indicating strong preference for
trimethylated peptide.
Mechanistically, multiple methyl marks can be demethylated
either distributively or processively, depending on whether
peptide substrates dissociate or remain enzyme-bound be-
tween consecutive demethylations. Our findings indicate that
the catalytic domain of JMJD2A by itself is distributive in its
action. The release of the dimethyl intermediate may have a
significant impact on the regulation of transcription. For
example, HP1 is recruited to heterochromatic loci by specific
association with H3 K9me2/3, while sites containing H3
K9me1/0 generally lack HP1 and remain euchromatic (Bannis-
ter et al., 2001; Canzio et al., 2011; Fischle et al., 2008; Grewal
and Jia, 2007; Lachner et al., 2001). Thus, in one possible
scenario, the release of the dimethyl peptide may serve as
an additional checkpoint before full commitment to the func-
tional output signaled by the monomethylated state. Moreover,
the observation that the dimethylated peptide is a 10-fold
poorer substrate than the trimethylated peptide raises the
possibility that demethylation of dimethylated substrates may,
in some instances, be carried out by other demethylases. For
example, in the context of androgen receptor-mediated
transcription, JMJD2C associates with a flavoprotein demethy-
lase LSD1, and in this complex, LSD1 acts on mono- and
dimethyl H3 K9 marks (Metzger et al., 2005; Wissmann et al.,
2007). Like JMJD2C, JMJD2A is also known to associate
with LSD1 in an androgen-receptor-dependent fashion (Kauff-
man et al., 2011).
Our data further imply that cJMJD2A does not significantly
discriminate between histone tail peptide and nucleosomal sub-
strates. The kcat/KM values for these two substrates are within
2.5-fold of one another: kcat/KM (ARKC9me3STGGK) = 1.5 3
103 mM1min1 and kmax/K0M (H3 KC9me3 Nuc) = 0.67 3 10
3
mM1min1. This result implies that the catalytic domain ofChemistry & Biology 20, 494–499, April 18, 2013JMJD2A predominantly recognizes resi-
dues immediately surrounding the H3 K9
and does not recognize additional fea-
tures on the nucleosome. Recognition of
other chromatin features or other modifi-
cations by the double Tudor or PHD do-
mains of the full-length demethylase
may result in tighter association and an in-
crease in demethylase activity. Such
additional interactions may also increase
the processivity of the catalytic domain.
By analogy, protein-interacting partnersmay also contribute to the regulation of activity and processivity.
In vivo, it is plausible that, in the presence of the relevant chro-
matin marks and/or protein partners, full-length JMJD2A may
demethylate in a processive manner. Such regulation of pro-
cessivity would have significant implications for controlling
the specific output of JMJD2A proteins in a context-dependent
manner (Bua et al., 2009; Collins et al., 2008; Iwase et al.,
2007; Kim et al., 2006; Rottach et al., 2010).
Overall, our ability to quantitatively assess the removal of
methyl marks from site-specifically methylated nucleosomes
by a demethylase is the necessary first step in further detailed in-
vestigations of chromatin modification by demethylases and de-
methylase-containing protein complexes. These studies will also
address the importance of the crosstalk between chromatin
marks in the regulation of histone methylation.
SIGNIFICANCE
Histone lysine methylation within nucleosomes is a revers-
ible process catalyzed by opposing actions of histone
methyltransferases and histone demethylases. As precise
control of the methylation extent of nucleosomes is
required for proper gene expression, nucleosome methyl-
ation must be tightly regulated. Jumonji histone demethy-
lases are a class of Fe(II) and a-ketoglutarate-dependent
dioxygenases that catalyze methyl removal from a number
of methylated lysine residues, and their misregulation is
correlated with diseases. By quantitatively analyzing the
demethylation activity of a catalytic construct of JMJD2A,
a member of the human Jumonji demethylases, we provide
insight into the ability of a prototypic member of the family
to remove a methyl mark. The results point to two important
features of the cJMJD2A: an intrinsic distributive nature and
its predominant recognition of the histone tail segment sur-
rounding the methyl lysine residue. Our studies directly
raise the possibility that the activity and processivity of
the catalytic domain may be regulated in a context-specific
manner by domains outside the catalytic domain. The
method developed here will enable future quantitativeª2013 Elsevier Ltd All rights reserved 497
Figure 4. Kinetic Analysis of cJMJD2A-
Mediated Demethylation of MLA-Contain-
ing Peptides and Nucleosomes
(A) Preparation of recombinant homogeneous H3
KC9me3 nucleosomes. Recombinant histone H3
K9C was alkylated with (2-bromoethyl)trimethy-
lammonium bromide to form H3 KC9me3 histones.
Subsequent assembly with histone H2A, H2B, H4,
and 601 sequence DNA provided homogeneous
H3 KC9me3 nucleosomes.
(B) Michaelis-Menten plot for demethylation of
MLA-containing peptide.
(C) Western blot analysis of an experiment per-
formed at 350 mM cJMJD2A. Data analysis and
extrapolation of kobs is described in Experimental
Procedures.
(D) Kinetics of demethylation of MLA-containing
nucleosomes. Data were obtained from three in-
dependent experiments and represented as
mean ± SEM.
See also Figures S2 and S3.
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well as interacting proteins of demethylases in regulating
demethylation of nucleosomes.
EXPERIMENTAL PROCEDURES
Demethylation of Nucleosomes
Demethylations of nucleosomes were performed by incubation of nucleo-
somes containing H3KC9me3 (300 nM)with a-ketoglutarate (1mM), ascorbate
(1 mM), varying concentrations of cJMJD2A (50–400 mM), and Fe(NH4)2(SO4)2
(twice the concentration of cJMJD2A) in 50 mM HEPES (pH 7.5) at room tem-
perature. Reactions were initiated by the addition of methylated nucleosomes.
Time points were quenched using a 3:1 mixture of 63 SDS sample loading
buffer and 0.5 M EDTA, pH 8.0, and boiled at 100C for 2 min. Samples
were run on 15% Criterion gels at 200 V for 40 min and transferred onto Im-
mun-blot PVDF membranes (Bio-Rad) at 4C for 2 hr at 600 mA. Membranes
were blocked at room temperature in 10 ml Odyssey Blocking Buffer (LI-COR
Biosciences) for 75 min and then incubated overnight with H3 K9me3 antibody
(Upstate 07-442, Lot: 2017310) and H4 antibody (Active Motif 39269, Lot:
11908001) at 1:800 and 1:1,000 dilutions, respectively, in a 1:1 mixture of
13 PBS and Odyssey Blocking Buffer containing 0.02% Tween-20 at 4C.
Membranes were subsequently washed with 13 TBS and 0.05% Tween-20
(four times, 4 min each), and then incubated with IRDye 680LT goat antirabbit
secondary antibody (LI-COR 926-68021, Lot: C10628-01) at 1:20,000 dilutions
in a 1:1 mixture of 13 PBS and Odyssey Blocking Buffer containing 0.02%
Tween-20 for 40 min at room temperature. Following this, membranes were
washed as described earlier and analyzed using Odyssey Application Soft-
ware (LI-COR Biosciences).
Data were analyzed by dividing fluorescent antibody signal of H3 KC9me3
by that of H4. These ratios were normalized to the H3 KC9me3/H4 ratio
at time 0, graphed as a function of time, and fitted to the equation498 Chemistry & Biology 20, 494–499, April 18, 2013 ª2013 Elsevier[H3 KC9me3] = [H3 KC9me3]t=0 e
kobst. Obtained kobs values were then
graphed against cJMJD2A concentrations and fit to kobs = (kmaxX)/(X+K
0
M)
with nonlinear regression to determine kmax and K
0
M parameters, where X
is the concentration of cJMJD2A.SUPPLEMENTAL INFORMATION
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